BRCA1 and BRCA2 families and the risk of skin cancer

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 489-493

  Ginsburg, Ophira M ^a,b   Kim Sing, Charmaine ^c   Foulkes, William D ^d   Ghadirian, Parviz ^e   Lynch, Henry T ^f   Sun, Ping ^b   Narod, Steven A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Cohort study; Melanoma; Skin cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SKIN CANCER;

BRCA1 PROTEIN; BRCA2 PROTEIN; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MALE; MELANOMA; MUTATION; PEDIGREE; RISK FACTORS; SKIN NEOPLASMS;

EID: 78650214348     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9377-y     Document Type: Article

References (48)

1. D Ford D Easton T Bishop S Narod, et al. 1994 Risk of cancer in BRCA1 mutation carriers Lancet 343 692 695 1:STN:280:DyaK2c7otVKitQ%3D%3D 10.1016/S0140-6736(94)91578-4 7907678 (Pubitemid 24087847)
2. The Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1310 1316 10.1093/jnci/91.15.1310
3. D Thompson DF Easton 2002 Breast cancer linkage consortium. Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 1358 1365 1:CAS:528:DC%2BD38Xnt1Gnurs%3D 12237281 (Pubitemid 35154140)
4. M Brose T Rebbeck K Calzone, et al. 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a cancer risk evaluation program J Natl Cancer Inst 94 1365 1372 1:CAS:528:DC%2BD38Xnt1Gnurg%3D 12237282 (Pubitemid 35154141)
5. O Johannsson N Loman T Moller U Kristoffersson A Borg H Olsson 1999 Incidence of malignant tumors in relatives of BRCA1 and BRCA2 germ-line mutation carriers Eur J Cancer 35 1248 1257 1:STN:280:DC%2BD3c%2Fot1Squw%3D%3D 10.1016/S0959-8049(99)00135-5 10615237 (Pubitemid 29359186)
6. JL Bermejo K Hemminki 2004 Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing Ann Oncol 15 1834 1841 10.1093/annonc/mdh474 (Pubitemid 40012250)
7. H Shih K Nathanson S Seal N Collins M Stratton T Rebbeck B Weber 2000 BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers Clin Cancer Res 6 4259 4264 1:CAS:528:DC%2BD3cXovVSgtbc%3D 11106241
8. D Easton L Steele P Fields W Ormiston, et al. 1997 Cancer risks in two large breast cancer families linked to BRCA2 on Chromosome 13q12-13 Am J Hum Genet 61 120 128 1:STN:280:DyaK2szovVOmuw%3D%3D 10.1086/513891 9245992 (Pubitemid 27323331)
9. R Moslehi W Chu B Karlan, et al. 2000 BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 1259 1272 1:CAS:528:DC%2BD3cXntV2isrc%3D 10.1086/302853 10739756 (Pubitemid 30468783)
10. H Risch J McLaughlin D Cole B Rosen, et al. 2001 Prevalence of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 700 710 1:CAS:528:DC%2BD3MXit1aksr8%3D 10.1086/318787 11179017 (Pubitemid 32203724)
11. P Aretini E D' Andrea B Pasini A Viel, et al. 2003 Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation Breast Cancer Res Treat 81 71 79 1:CAS:528:DC%2BD3sXms1Gjs78%3D 10.1023/A:1025428807472 14531499 (Pubitemid 37108442)
12. J Streuwing P Hartge S Wacholder, et al. 1997 The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1401 1408 10.1056/NEJM199705153362001 (Pubitemid 27208598)
13. DE Goldgar DF Easton L Cannon-Albright M Skolnick 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands J Natl Cancer Inst 86 1600 1608 1:STN:280:DyaK2M%2FhvVeguw%3D%3D 10.1093/jnci/86.21.1600 7932824 (Pubitemid 24336346)
14. D Berman J Costalas D Schultz G Grana M Daly A Godwin 1996 A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish and non-Jewish individuals Cancer Res 56 3409 3414 1:CAS:528: DyaK28Xks1els78%3D 8758903 (Pubitemid 26251628)
15. S Hahn B Greenhalf I Ellis M Sina-Frey, et al. 2003 BRCA2 germline mutations in familial pancreatic carcinoma J Natl Cancer Inst 95 214 221 1:CAS:528:DC%2BD3sXit1emsL0%3D 10.1093/jnci/95.3.214 12569143 (Pubitemid 36240634)
16. K Murphy K Brune C Griffin J Sollenberger, et al. 2002 Evaluation of candidate genes MPP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% Cancer Res 62 3789 3793 1:CAS:528: DC%2BD38XltF2jur0%3D 12097290 (Pubitemid 34728862)
17. G Lal G Liu B Schmocker, et al. 2000 Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1 and BRCA2 mutations Cancer Res 60 409 416 1:CAS:528:DC%2BD3cXhtVahsb8%3D 10667595 (Pubitemid 30070770)
18. T Kirchhoff N Kauff N Mitra, et al. 2004 BRCA mutations and the risk of prostate cancer in Ashkenazi Jews Clin Cancer Res 10 2918 2921 1:CAS:528:DC%2BD2cXjs12lsL4%3D 10.1158/1078-0432.CCR-03-0604 15131025 (Pubitemid 38619665)
19. SM Edwards Z Kote-Jarai J Meitz, et al. 2003 Two percent of men with early onset prostate cancer harbor germline mutations in the BRCA2 gene Am J Hum Genet 72 1 12 1:CAS:528:DC%2BD3sXis1yhtg%3D%3D 10.1086/345310 12474142 (Pubitemid 36056838)
20. A Vazina J Baniel A Shtriker, et al. 2000 The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel Br J Cancer 83 463 466 1:CAS:528:DC%2BD3cXmtFOmt7o%3D 10.1054/bjoc.2000.1249 10945492 (Pubitemid 30487858)
21. A Hubert T Peretz O Manor, et al. 1999 The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer Am J Hum Genet 65 921 924 1:STN:280:DyaK1MznsFSntw%3D%3D 10.1086/302525 10441598 (Pubitemid 30468737)
22. S Thorlacius J Struewing P Hartge, et al. 1998 Population based study of risk of breast cancer in carriers of BRCA2 mutation Lancet 352 1337 1339 1:STN:280:DyaK1M%2FhslamtA%3D%3D 10.1016/S0140-6736(98)03300-5 9802270 (Pubitemid 28510913)
23. S Sigurdsson S Thorlaciaus J Tomasson, et al. 1997 BRCA2 mutation in Icelandic prostate cancer patients J Mol Med 75 758 761 1:STN:280: DyaK1c%2Fktlenug%3D%3D 10.1007/s001090050162 9383000 (Pubitemid 27451978)
24. J Iscovich M Abdulrazik C Cour, et al. 2002 Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients Int J Cancer 98 42 44 1:CAS:528:DC%2BD38Xht1WgsLc%3D 10.1002/ijc.10155 11857383 (Pubitemid 34113416)
25. R Scott C Vajdic B Armstrong, et al. 2002 BRCA2 mutations in a population based series of patients with ocular melanoma Int J Cancer 102 188 191 1:CAS:528:DC%2BD38XotFSjt70%3D 10.1002/ijc.10693 12385017 (Pubitemid 35168034)
26. B Niell G Rennert J Bonner R Almog L Tomsho S Gruber 2004 BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer J Natl Cancer Inst 96 15 21 1:CAS:528:DC%2BD2cXislaktA%3D%3D 10.1093/jnci/djh008 14709734 (Pubitemid 38180955)
27. T Kirchhoff J Satagopan N Kauff, et al. 2004 Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer J Natl Cancer Inst 96 68 70 1:CAS:528:DC%2BD2cXislarsA%3D%3D 10.1093/jnci/djh006 14709740 (Pubitemid 38180961)
28. R Chen-Stoyerman A Figer H Fidder, et al. 2001 The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients Br J Cancer 84 475 477 10.1054/bjoc.2000.1598 (Pubitemid 32215872)
29. L Drucker R Stackievitz B Shpitz S Yarkoni 2000 Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study Anticancer Res 20 559 561 1:CAS:528:DC%2BD3cXisl2gu7c%3D 10769725 (Pubitemid 30189721)
30. CB Begg 2002 On the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 94 1221 1226 12189225 (Pubitemid 34993872)
31. CR Amos 2003 Re: on the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 95 74 75 1:CAS:528:DC%2BD3sXitlOnt7Y%3D 10.1093/jnci/95.1.74 12509406
32. H Risch S Narod 2003 Re: on the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 95 73 74 1:CAS:528:DC%2BD3sXitlOnt7k%3D 12509405
33. PP Pharoah A Antoniou J Hopper D Easton 2003 Re: on the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 95 75 76 1:CAS:528:DC%2BD3sXitlOnt7c%3D 10.1093/jnci/95.1.75 12509407
34. AS Whittemore G Gong 2003 Re: on the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 95 76 77 1:CAS:528:DC%2BD3sXitlOntL4%3D 10.1093/jnci/95.1.76 12509408
35. W Burke MA Austin 2003 Re: on the use of familial aggregation in population-based case probands for calculating penetrance J Natl Cancer Inst 95 78 79 1:CAS:528:DC%2BD3sXitlOntLw%3D 10.1093/jnci/95.1.78 12509410
36. DF Easton JL Hopper DL Thomas A Antoniou PDP Pharoah AS Whittemore 2004 Re: breast cancer risks for BRCA1/2 carriers Science 306 2187 2188 1:CAS:528:DC%2BD2cXhtFGnsL7I 10.1126/science.306.5705.2187c 15622557
37. S Wacholder JP Struewing P Hartage MH Greene MA Tucker 2004 Re: breast cancer risks for BRCA1/2 carriers Science 306 2188 1:CAS:528:DC%2BD2cXhtFGnsL7J
38. MC King New York Breast Cancer Study Group 2004 Re: breast cancer risks for BRCA1/2 carriers Science 306 2188 2191 1:CAS:528:DC%2BD2cXhtFGnsL7E
39. K Offit 2006 BRCA mutation frequency and penetrance: new data, old debate J Natl Cancer Inst 98 23 1675 1677 10.1093/jnci/djj500 17148764 (Pubitemid 44942706)
40. DR Easton D Ford DT Bishop 1995 Breast and ovarian incidence in BRCA1-mutartion carriers Am J Hum Genet 56 256 271
41. N Loman A Bladstrom O Johannsson A Borg H Olsson 2003 Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status Breast Cancer Res 5 R175 R186 10.1186/bcr632 14580253
42. DL Miller MA Weinstock 1994 Nonmelanoma skin cancer in the United States: incidence J Am Acad Derm 30 774 778 1:STN:280:DyaK2c3jtVOgtw%3D%3D 10.1016/S0190-9622(08)81509-5 8176018 (Pubitemid 24157120)
43. SEER 17 (2000-2006). http://seer.cancer.gov
44. E Levy-Lahad E Friedman 2007 Cancer risks among BRCA1 and BRCA2 carriers: minireview British J Cancer 96 11 15 1:CAS:528:DC%2BD2sXis1Kntw%3D%3D 10.1038/sj.bjc.6603535 (Pubitemid 46094632)
45. J Iscovitch M Abdulrazik C Cour, et al. 2002 Prevalence of the BRCA2 6174delT mutation in uveal melanoma patients Int J Cancer 98 42 44 10.1002/ijc.10155 (Pubitemid 34113416)
46. L Kadouri M Temper T Grenader D Abeliovich T Hamburger T Peretz M Lotem 2009 Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin Fam Cancer 8 29 32 1:CAS:528: DC%2BD1MXhsFWntbs%3D 10.1007/s10689-008-9206-8 18679827
47. C Monerrat A Chompret C Kannengiesser M-F Avril, et al. 2007 BRCA1, BRCA2, CDKN2a germline mutations in patients with breast cancer and cutaneous melanoma Fam Cancer 6 453 461 10.1007/s10689-007-9143-y (Pubitemid 47622260)
48. A Navaraj T Mori WS El-Deiry 2005 Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers Cancer Biol Ther 4 1409 1414 1:CAS:528:DC%2BD28XkvVOgsrc%3D 16357511 (Pubitemid 43131189)